Lin Chih-Yu, Li Wei-Peng, Huang Shao-Peng, Yeh Chen-Sheng, Yang Chia-Min
Department of Chemistry, National Tsing Hua University, Hsinchu 30013, Taiwan.
J Mater Chem B. 2017 Sep 28;5(36):7598-7607. doi: 10.1039/c7tb01812f. Epub 2017 Sep 6.
A facile preparation of a nanocomposite comprising FePt nanoparticles (NPs) and hollow mesoporous silica nanospheres (HMSNs) was reported. The bimetallic NPs had an alloy structure with Pt-rich cores and were highly dispersed on the mesoporous shell of HMSNs. The material, designated as FePt@MMT-2, could be gradually degraded and dissolved under physiological conditions and showed low cytotoxicity against HeLa cells. FePt@MMT-2 exhibited ferromagnetic-like properties and broadband near-infrared (NIR) absorption along with high photothermal transduction efficiency. In addition, in vitro studies showed high efficacy of FePt@MMT-2 in killing HeLa cells with 1064 nm NIR irradiation, and synergistic anticancer effects when combined with chemo drug topotecan. The results demonstrated the potential of the designed nanocomposite for theranostic applications.
报道了一种制备包含FePt纳米颗粒(NPs)和中空介孔二氧化硅纳米球(HMSNs)的纳米复合材料的简便方法。双金属NPs具有富Pt核的合金结构,并高度分散在HMSNs的介孔壳上。这种材料被命名为FePt@MMT-2,在生理条件下可逐渐降解和溶解,并且对HeLa细胞显示出低细胞毒性。FePt@MMT-2表现出类似铁磁的性质以及宽带近红外(NIR)吸收,同时具有高光热转换效率。此外,体外研究表明,FePt@MMT-2在1064 nm NIR照射下对HeLa细胞具有高效杀伤作用,并且与化疗药物拓扑替康联合使用时具有协同抗癌效果。结果证明了所设计的纳米复合材料在诊疗应用中的潜力。